Sarepta Therapeutics Inc (SRPT)
Healthcare
Biotechnology
15.90 $
+6.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -205 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -129 | -149 | -246 | -232 | -389 | -456 | 107 | -443 | -325 | -501 | -206 | -205 | |
| 3.7 | 5.2 | 5.6 | 8.1 | 12 | 25 | 27 | 38 | 42 | 44 | 38 | 45 | |
| 20 | 32 | 30 | 30 | 50 | 79 | 108 | 114 | 233 | 183 | 184 | 123 | |
| 23 | 33 | 31 | -91 | 77 | 274 | 178 | 32 | 376 | – | – | – | |
| -22 | 32 | -16 | -97 | -108 | -67 | 554 | -98 | -39 | -481 | -717 | 78 | |
| 27 | 4.8 | 6.9 | 21 | 64 | 60 | 82 | 38 | 32 | 87 | 147 | 102 | |
| -159 | 8.4 | -90 | -179 | -370 | 287 | -122 | 495 | -1,047 | -166 | 756 | 70 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 241 | 286 | – | – | – | – | – | |
| 104 | 131 | 365 | 354 | 564 | -4.3 | -4.8 | -7.8 | – | 0.0 | 0.0 | -25 | |
| -0.1 | 17 | -7.6 | 570 | -3.5 | 245 | 291 | 304 | 304 | 0.0 | -0.1 | -163 | |
| 104 | 148 | 378 | 888 | 530 | 643 | 682 | 562 | 233 | 125 | 125 | -168 | |
| -183 | 6.8 | 42 | 477 | -229 | 473 | 668 | 614 | -1,140 | -542 | 675 | -304 | |
| -155 | -154 | -253 | -253 | -453 | -516 | 25 | -482 | -358 | -588 | -353 | -307 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.